loader
Please Wait
Applying Filters...

Looking for Co-Processed Excipients? Find Co-Processed Excipients Agents used in Aprepitant to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 15,881Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Rochem International Inc

02 2SPI Pharma

03 1Faran Shimi Pharmaceutical

04 12Gangwal Healthcare

05 5Kerry

06 2Pluviaendo

07 2Roquette

08 2Shijiazhuang Huaxu Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Grade : Oral

Brand Name : Mannitol

Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Ingredient(s) : Mannitol

Dosage Form : Tablet

Category : Fillers, Diluents & Binders, Taste Masking

Brand : MANNITOL

Applications : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

arrow

03

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Grade : Oral

Brand Name : Mannitol

Excipient Details : Mannitol is a co-processed excipient with superior compactibility, lower disintegration time, and hygroscopicity.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Ingredient(s) : Mannitol

Dosage Form : Tablet

Category : Co-Processed Excipients

Brand : MANNITOL

Applications : Mannitol is a co-processed excipient with superior compactibility, lower disintegration time, and hygroscopicity.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

arrow

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

Brand Name : Microlose™ M60 P60

Excipient Details : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : MICROLOSE™ M60 P60

Applications : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

Grade : Oral

arrow

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : DICOM-DC® S604

Applications : DiCOM-DC S604 is used as a DC co-processed excipient with a combination of various polymers that act as fillers and binders in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Polyvinyl Pyrrolidone 97% & 93%

Grade : Oral

arrow

11

arrow
Fi Europe 2024
Not Confirmed